Patents by Inventor Hiroki Urabe

Hiroki Urabe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210288833
    Abstract: An information notification system includes apparatuses and first server. The apparatuses include a first device. Each of at least one of the apparatuses includes a sensor unit that senses whether any person is present and generates a presence-absence signal including person presence-absence information. A first device includes a generator that generates a notification signal including notification information that is to be provided to the user. A first server includes an information acquirer that acquires the person presence-absence information, and a presentation controller that determines a presumed position and causes a second device to present the notification information, and the second device being one of one or more apparatuses that are capable of presenting the notification information to the person who is in the presumed position among the apparatuses. A presentation controller changes a form of presentation in accordance with presentation setting information that is information about the person.
    Type: Application
    Filed: February 20, 2020
    Publication date: September 16, 2021
    Inventors: Kohsuke YAMAMOTO, Masahiro OHHO, Seigo TAKAHASHI, Hiroki URABE
  • Publication number: 20210158682
    Abstract: An information notification system includes apparatuses and a first server. The apparatuses include a first device. Each of at least one of the apparatuses includes a sensor unit that discriminates between at least one person and generates a presence-absence signal including presence-absence information about each person. A first device includes a generator that generates a notification signal including notification information that is to be provided to the user and user information for use in identifying the user. A first server includes an information acquirer that acquires the user information, the notification information, and the presence-absence information, and a presentation controller that determines a presumed position of the user presumed based on the user information and the presence-absence information and causes one of apparatuses that are capable of presenting the notification information to the user who is in the presumed position among the apparatuses to present the notification information.
    Type: Application
    Filed: February 20, 2020
    Publication date: May 27, 2021
    Inventors: Kohsuke YAMAMOTO, Masahiro OHHO, Seigo TAKAHASHI, Hiroki URABE
  • Publication number: 20210147400
    Abstract: Provided is a novel process for producing a (2S)-2-[(1H-pyrazol-1-yl)methyl]-1,3-oxazinane derivative. More specifically, provided is a process for producing a (2S)-2-[(1H-pyrazol-1-yl)methyl]-1,3-oxazinane derivative represented by formula (1): the process comprising reacting 3-aminopropan-1-ol with glyoxylic acid.
    Type: Application
    Filed: July 11, 2018
    Publication date: May 20, 2021
    Applicant: TAISHO PHARMACEUTICAL CO., LTD.
    Inventors: Takaaki MATSUBARA, Hiroki URABE, Ryo SUZUKI, Aya FUTAMURA, Ryo KINOSHITA, Nobutaka HATTORI, Hideaki TABUSE, Koreaki IMURA, Norikazu OTAKE
  • Patent number: 10863228
    Abstract: A control device includes: an output unit that outputs a signal for prompting an electronic device to execute a predetermined operation; a function switch unit that includes a plurality of switches each having a contactor formed such that at least a portion of the contactor is elastically displaceable in a predetermined direction; and a label body that has a display part and a protruding part protruding from the display part, the label body being mounted in a state where the protruding part is inserted into a hole in a housing and the display part is positioned on an outside of the housing. The protruding part of the label body determines a combination of open or closed states of the plurality of switches. The predetermined operation is determined according to the combination.
    Type: Grant
    Filed: March 28, 2017
    Date of Patent: December 8, 2020
    Assignee: PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.
    Inventors: Norikazu Kaneshiro, Yutaka Higurashi, Hiroki Urabe, Tsukasa Takahashi, Makoto Sekitoh
  • Publication number: 20190098247
    Abstract: A control device includes: an output unit that outputs a signal for prompting an electronic device to execute a predetermined operation; a function switch unit that includes a plurality of switches each having a contactor formed such that at least a portion of the contactor is elastically displaceable in a predetermined direction; and a label body that has a display part and a protruding part protruding from the display part, the label body being mounted in a state where the protruding part is inserted into a hole in a housing and the display part is positioned on an outside of the housing. The protruding part of the label body determines a combination of open or closed states of the plurality of switches. The predetermined operation is determined according to the combination.
    Type: Application
    Filed: March 28, 2017
    Publication date: March 28, 2019
    Inventors: NORIKAZU KANESHIRO, YUTAKA HIGURASHI, HIROKI URABE, TSUKASA TAKAHASHI, MAKOTO SEKITOH
  • Patent number: 9499477
    Abstract: Provided is a novel compound which is useful as a pharmaceutical composition by inhibiting an LpxC activity, thereby exhibiting potent antimicrobial activity against gram-negative bacteria including Pseudomonas aeruginosa and its drug resistant bacteria. Provided is a hydroxamic acid derivative represented by the following general formula [1] or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 21, 2015
    Date of Patent: November 22, 2016
    Assignees: TOYAMA CHEMICAL CO., LTD., TAISHO PHARMACEUTICAL CO., LTD
    Inventors: Hajime Takashima, Risa Tsuruta, Tetsuya Yabuuchi, Yusuke Oka, Hiroki Urabe, Yoichiro Suga, Masato Takahashi, Fumito Uneuchi, Hironori Kotsubo, Muneo Shoji, Yasuko Kawaguchi
  • Publication number: 20150225335
    Abstract: Provided is a novel compound which is useful as a pharmaceutical composition by inhibiting an LpxC activity, thereby exhibiting potent antimicrobial activity against gram-negative bacteria including Pseudomonas aeruginosa and its drug resistant bacteria.
    Type: Application
    Filed: April 21, 2015
    Publication date: August 13, 2015
    Applicants: TAISHO PHARMACEUTICAL CO., LTD., TOYAMA CHEMICAL CO., LTD.
    Inventors: Hajime TAKASHIMA, Risa TSURUTA, Tetsuya YABUUCHI, Yusuke OKA, Hiroki URABE, Yoichiro SUGA, Masato TAKAHASHI, Fumito UNEUCHI, Hironori KOTSUBO, Muneo SHOJI, Yasuko KAWAGUCHI
  • Patent number: 9073821
    Abstract: Provided is a novel compound which is useful as a pharmaceutical composition by inhibiting an LpxC activity, thereby exhibiting potent antimicrobial activity against gram-negative bacteria including Pseudomonas aeruginosa and its drug resistant bacteria.
    Type: Grant
    Filed: April 20, 2011
    Date of Patent: July 7, 2015
    Assignees: TAISHO PHARMACEUTICAL CO., LTD, TOYAMA CHEMICAL CO., LTD.
    Inventors: Hajime Takashima, Risa Tsuruta, Tetsuya Yabuuchi, Yusuke Oka, Hiroki Urabe, Yoichiro Suga, Masato Takahashi, Fumito Uneuchi, Hironori Kotsubo, Muneo Shoji, Yasuko Kawaguchi
  • Patent number: 8729271
    Abstract: The present invention aims to provide novel compounds of formula [I] or pharmaceutically acceptable salts thereof that are based on a glycine uptake inhibiting action and which are useful in the prevention or treatment of such diseases as schizophrenia, Alzheimer's disease, cognitive dysfunction, dementia, anxiety disorders (generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, social anxiety disorder, posttraumatic stress disorder, specific phobia, acute stress disorder, etc.
    Type: Grant
    Filed: September 16, 2011
    Date of Patent: May 20, 2014
    Assignee: Taisho Pharmaceutical Co., Ltd
    Inventors: Minoru Moriya, Akito Yasuhara, Kazunari Sakagami, Hiroshi Ohta, Kumi Abe, Shuji Yamamoto, Yuko Araki, Hiroki Urabe, Xiang-Min Sun
  • Publication number: 20130342663
    Abstract: The instant application discloses an eyewear device including: a light amount adjuster which adjusts a light amount transmitted to left and right eyes of an observer to perform assistance operation that assists in observing a video so that the video is stereoscopically perceived; a battery portion which stores power for the light amount adjuster to perform the assistance operation; and a transmitter configured to transmit a notification signal for notifying a condition of the battery portion. The notification signal contains charge information, which indicates whether or not the battery portion is being charged, and remaining level information, which indicates a power amount stored in the battery portion.
    Type: Application
    Filed: June 3, 2013
    Publication date: December 26, 2013
    Inventors: Yoshihiro HARA, Hiroki URABE
  • Patent number: 8524738
    Abstract: A nitrogen-containing heterocyclic compound or pharmaceutically acceptable salt thereof represented by the general formula: which have a potent antibacterial activity and a high safety. Thus, the compounds are useful as antibacterial agents against gram-positive bacteria, gram-negative bacteria and drug resistant bacteria.
    Type: Grant
    Filed: May 3, 2012
    Date of Patent: September 3, 2013
    Assignees: Toyama Chemical Co., Ltd., Taisho Pharmaceutical Co., Ltd.
    Inventors: Taro Kiyoto, Tadashi Tanaka, Yasuhiro Tsutsui, Junichi Ando, Mai Motono, Yasuko Kawaguchi, Toshiya Noguchi, Yasunobu Ushiki, Fumihito Ushiyama, Hiroki Urabe
  • Publication number: 20130184460
    Abstract: The present invention aims to provide novel compounds of formula [I] or pharmaceutically acceptable salts thereof that are based on a glycine uptake inhibiting action and which are useful in the prevention or treatment of such diseases as schizophrenia, Alzheimer's disease, cognitive dysfunction, dementia, anxiety disorders (generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, social anxiety disorder, posttraumatic stress disorder, specific phobia, acute stress disorder, etc.
    Type: Application
    Filed: September 16, 2011
    Publication date: July 18, 2013
    Applicant: TAISHO PHARMACEUTICAL CO., LTD.
    Inventors: Minoru Moriya, Akito Yasuhara, Kazunari Sakagami, Hiroshi Ohta, Kumi Abe, Shuji Yamamoto, Yuko Araki, Hiroki Urabe, Xiang-Min Sun
  • Publication number: 20130137865
    Abstract: A compound represented by formula [I] and a pharmaceutically accepted salt of said compound are a novel compound and a pharmaceutically accepted salt thereof which exert antagonistic activity against group II metabotropic glutamate (mGlu) receptors, and are effective as a novel preventive or therapeutic agent for disorders such as mood disorders (depressive disorder, bipolar disorder, etc.), anxiety disorders (generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, social anxiety disorder, posttraumatic stress disorder, a specific phobic disorder, acute stress disorder, etc.), schizophrenia, Alzheimer's disease, cognitive impairment, dementia, drug dependence, convulsions, shivering, pain, sleep disorders, and the like.
    Type: Application
    Filed: August 11, 2011
    Publication date: May 30, 2013
    Applicant: TAISHO PHARMACEUTICAL CO., LTD.
    Inventors: Toshio Nakamura, Kazunari Sakagami, Kazuhide Konishi, Kanako Yamamoto, Seiji Masuda, Yohei Matsuda, Kumiko Okada, Tsuyoshi Shibata, Hiroshi Ohta, Akito Yasuhara, Hiroshi Kawamoto, Hideaki Amada, Hiroki Urabe, Rie Nishikawa, Shuhei Kashiwa ASHIWA
  • Publication number: 20130072677
    Abstract: Provided is a novel compound which is useful as a pharmaceutical composition by inhibiting an LpxC activity, thereby exhibiting potent antimicrobial activity against gram-negative bacteria including Pseudomonas aeruginosa and its drug resistant bacteria.
    Type: Application
    Filed: April 20, 2011
    Publication date: March 21, 2013
    Applicants: TOYAMA CHEMICAL CO., LTD., TAISHO PHARMACEUTICAL CO., LTD
    Inventors: Hajime Takashima, Risa Tsuruta, Tetsuya Yabuuchi, Yusuke Oka, Hiroki Urabe, Yoichiro Suga, Masato Takahashi, Fumito Uneuchi, Hironori Kotsubo, Muneo Shoji, Yasuko Kawaguchi
  • Patent number: 8367831
    Abstract: Disclosed is a compound represented by the general formula: wherein R1 represents an aryl or heterocyclic group which may be substituted or the like; X1 represents a C2-C4 alkylene group or the like; X2, X3 and X5 independently represent NH, a bond or the like; X4 represents a lower alkylene group, a bond or the like; Y1 represents a bivalent alicyclic hydrocarbon residue which may be substituted or a bivalent alicyclic amine residue which may be substituted; and Z1, Z2, Z3, Z4, Z5 and Z6 independently represent a nitrogen atom, a group represented by the formula: CH, or the like, provided that at least one of Z3, Z4, Z5 and Z6 represents a nitrogen atom, or a salt thereof, which is useful as an antibacterial agent.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: February 5, 2013
    Assignees: Toyama Chemical Co., Ltd., Taisho Pharmaceutical Co., Ltd.
    Inventors: Taro Kiyoto, Junichi Ando, Tadashi Tanaka, Yasuhiro Tsutsui, Mai Yokotani, Toshiya Noguchi, Fumihito Ushiyama, Hiroki Urabe, Hiromasa Horikiri
  • Patent number: 8354426
    Abstract: Disclosed is 1-(2-(4-((2,3-dihydro(1,4)dioxino(2,3-c)pyridin-7-ylmethyl)amino)piperidin-1-yl)ethyl)-7-fluoro-1,5-naphthyridin-2(1H)-one monohydrate, which has strong antibacterial activity. The compound is highly safe and useful as an original drug for pharmaceutical preparations. Also disclosed is a method which is useful for producing 1-(2-(4-((2,3-dihydro(1,4)dioxino(2,3-c)pyridin-7-ylmethyl)amino)piperidin-1-yl)ethyl)-7-fluoro-1,5-naphthyridin-2(1H)-one monohydrate.
    Type: Grant
    Filed: November 25, 2008
    Date of Patent: January 15, 2013
    Assignees: Toyama Chemical Co., Ltd., Taisho Pharmaceutical Co., Ltd.
    Inventors: Taro Kiyoto, Masahiro Takebayashi, Yasutaka Baba, Muneo Syoji, Toshiya Noguchi, Fumihito Ushiyama, Hiroki Urabe, Hiromasa Horikiri
  • Patent number: 8329694
    Abstract: A nitrogen-containing heterocyclic compound or pharmaceutically acceptable salt thereof represented by the general formula: which have a potent antibacterial activity and a high safety. Thus, the compounds are useful as antibacterial agents against gram-positive bacteria, gram-negative bacteria and drug resistant bacteria.
    Type: Grant
    Filed: June 22, 2006
    Date of Patent: December 11, 2012
    Assignees: Toyama Chemical Co., Ltd., Taisho Pharmaceutical Co., Ltd.
    Inventors: Taro Kiyoto, Tadashi Tanaka, Yasuhiro Tsutsui, Junichi Ando, Mai Motono, Yasuko Kawaguchi, Toshiya Noguchi, Yasunobu Ushiki, Fumihito Ushiyama, Hiroki Urabe
  • Publication number: 20120226035
    Abstract: Disclosed is a compound represented by the general formula: wherein R1 represents an aryl or heterocyclic group which may be substituted or the like; X1 represents a C2-C4 alkylene group or the like; X2, X3 and X5 independently represent NH, a bond or the like; X4 represents a lower alkylene group, a bond or the like; Y1 represents a bivalent alicyclic hydrocarbon residue which may be substituted or a bivalent alicyclic amine residue which may be substituted; and Z1, Z2, Z3, Z4, Z5 and Z6 independently represent a nitrogen atom, a group represented by the formula: CH, or the like, provided that at least one of Z3, Z4, Z5 and Z6 represents a nitrogen atom, or a salt thereof, which is useful as an antibacterial agent.
    Type: Application
    Filed: May 10, 2012
    Publication date: September 6, 2012
    Applicants: Taisho Pharmaceutical Co., Ltd., Toyama Chemical Co., Ltd.
    Inventors: Taro KIYOTO, Junichi Ando, Tadashi Tanaka, Yasuhiro Tsutsui, Mai Yokotani, Toshiya Noguchi, Fumihito Ushiyama, Hiroki Urabe, Hiromasa Horikiri
  • Publication number: 20120214990
    Abstract: A nitrogen-containing heterocyclic compound or pharmaceutically acceptable salt thereof represented by the general formula: which have a potent antibacterial activity and a high safety. Thus, the compounds are useful as antibacterial agents against gram-positive bacteria, gram-negative bacteria and drug resistant bacteria.
    Type: Application
    Filed: May 3, 2012
    Publication date: August 23, 2012
    Applicants: TAISHO PHARMACEUTICAL CO., LTD., TOYAMA CHEMICAL CO., LTD.
    Inventors: Taro KIYOTO, Tadashi Tanaka, Yasuhiro Tsutsui, Junichi Ando, Mai Motono, Yasuko Kawaguchi, Toshiya Noguchi, Yasunobu Ushiki, Fumihito Ushiyama, Hiroki Urabe
  • Patent number: 8211908
    Abstract: Disclosed is a compound represented by the general formula: [wherein R1 represents an aryl or heterocyclic group which may be substituted or the like; X1 represents a C2-C4 alkylene group or the like; X2, X3 and X5 independently represent NH, a bond or the like; X4 represents a lower alkylene group, a bond or the like; Y1 represents a bivalent alicyclic hydrocarbon residue which may be substituted or a bivalent alicyclic amine residue which may be substituted; and Z1, Z2, Z3, Z4, Z5 and Z6 independently represent a nitrogen atom, a group represented by the formula: CH, or the like, provided that at least one of Z3, Z4, Z5 and Z6 represents a nitrogen atom] or a salt thereof, which is useful as an antibacterial agent.
    Type: Grant
    Filed: May 24, 2007
    Date of Patent: July 3, 2012
    Assignees: Toyama Chemical Co., Ltd., Taisho Pharmaceutical Co., Ltd.
    Inventors: Taro Kiyoto, Junichi Ando, Tadashi Tanaka, Yasuhiro Tsutsui, Mai Yokotani, Toshiya Noguchi, Fumihito Ushiyama, Hiroki Urabe, Hiromasa Horikiri